Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study.
Nakayama Y, Watanabe R, Yamamoto W, Ebina K, Hirano T, Kotani T, Shiba H, Katayama M, Son Y, Amuro H, Onishi A, Jinno S, Hara R, Murakami K, Murata K, Ito H, Tanaka M, Matsuda S, Morinobu A, Hashimoto M. Nakayama Y, et al. Among authors: watanabe r. Rheumatology (Oxford). 2024 Feb 1;63(2):349-357. doi: 10.1093/rheumatology/kead299. Rheumatology (Oxford). 2024. PMID: 37354495
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort.
Nakajima T, Doi H, Watanabe R, Murata K, Takase Y, Inaba R, Itaya T, Iwasaki T, Shirakashi M, Tsuji H, Kitagori K, Akizuki S, Nakashima R, Onishi A, Yoshifuji H, Tanaka M, Ito H, Hashimoto M, Ohmura K, Morinobu A. Nakajima T, et al. Among authors: watanabe r. Mod Rheumatol. 2023 Dec 22;34(1):113-121. doi: 10.1093/mr/road014. Mod Rheumatol. 2023. PMID: 36680424
Pathogenicity of IgG-Fc desialylation and its association with Th17 cells in an animal model of systemic lupus erythematosus.
Nishida Y, Shirakashi M, Hashii N, Nakashima R, Nakayama Y, Katsushima M, Watanabe R, Onizawa H, Hiwa R, Tsuji H, Kitagori K, Akizuki S, Onishi A, Murakami K, Yoshifuji H, Tanaka M, Tsuruyama T, Morinobu A, Hashimoto M. Nishida Y, et al. Among authors: watanabe r. Mod Rheumatol. 2024 Mar 28;34(3):523-529. doi: 10.1093/mr/road054. Mod Rheumatol. 2024. PMID: 37300805
Predictive value of baseline concomitant glucocorticoid for abatacept-mediated long-term inhibition of radiographic progression: insights from the KURAMA cohort.
Murakami K, Watanabe R, Fujisaki T, Ito H, Murata K, Yamamoto W, Fujii T, Onizawa H, Onishi A, Tanaka M, Hashimoto M, Morinobu A. Murakami K, et al. Among authors: watanabe r. Immunol Med. 2024 Mar;47(1):45-51. doi: 10.1080/25785826.2023.2265148. Epub 2023 Oct 3. Immunol Med. 2024. PMID: 37789658
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort.
Fujii T, Murata K, Onizawa H, Onishi A, Tanaka M, Murakami K, Nishitani K, Furu M, Watanabe R, Hashimoto M, Ito H, Fujii T, Mimori T, Morinobu A, Matsuda S. Fujii T, et al. Among authors: watanabe r. Arthritis Res Ther. 2024 Jan 9;26(1):16. doi: 10.1186/s13075-023-03251-z. Arthritis Res Ther. 2024. PMID: 38195572 Free PMC article.
2,182 results